References:

  1. Lim, Yizhe, et al. “Interstitial Cystitis/Bladder Pain Syndrome.” StatPearls, StatPearls Publishing, 7 October 2024.
  2. Marcu, Ioana et al. “Interstitial Cystitis/Bladder Pain Syndrome.” Seminars in reproductive medicine vol. 36,2 (2018): 123-135. doi:10.1055/s-0038-1676089
  3. Lee, Jongsoo et al. “Pentosan Polysulfate Sodium and Maculopathy in Patients with Interstitial Cystitis: A Systematic Review and Meta-Analysis.” The world journal of men’s health, 10.5534/wjmh.240295. 27 Feb. 2025, doi:10.5534/wjmh.240295
  4. Pearce WA, Chen R, Jain N. Pigmentary Maculopathy Associated with Chronic Exposure to Pentosan Polysulfate Sodium. Ophthalmology. 2018 Nov;125(11):1793-1802.
  5. Margines JB, Tripathy K, Hobbs SD. Pentosan Polysulfate Maculopathy. [Updated 2024 Mar 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK589706/
  6. Greenlee T, Hom G, Conti T, Babiuch AS, Singh R. Re: Pearce et al.: Pigmentary maculopathy associated with chronic exposure to pentosan polysulfate sodium (Ophthalmology. 2018;125:1793-1802). Ophthalmology. 2019 Jul;126(7):e51.
  7. Barnes AC, Hanif AM, Jain N. Pentosan Polysulfate Maculopathy versus Inherited Macular Dystrophies: Comparative Assessment with Multimodal Imaging. Ophthalmol Retina. 2020 Dec;4(12):1196-1201.
  8. Wang D, Au A, Gunnemann F, Hilely A, Scharf J, Tran K, Sun M, Kim JH, Sarraf D. Pentosan-associated maculopathy: prevalence, screening guidelines, and spectrum of findings based on prospective multimodal analysis. Can J Ophthalmol. 2020 Apr;55(2):116-125.